Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
July 3, 2015
[Diagnostic value of three evaluation methods of ¹⁸F-FDG PET/CT in detecting bone marrow infiltration in patients with newly diagnosed diffuse large B-cell lymphoma]
Jiefei Bai, Yingqiang Zhang, Minghui Duan, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
August 13, 2025
Exploring the Molecular Mechanisms and Biological Effects of CELF2 in the Development of Gastric Cancer
Weijian Li, Shengyong Zhai, Xuejian Wang, et al.
Iscience
|
May 1, 2023
Multiomic landscape of immune pathogenesis in Kimura's disease
Xunyao Wu, Anqi Wang, Sumei Zhang, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 12, 2025
TET2 mutations in myeloproliferative neoplasms: potential mediation of atrial fibrillation by interleukin-1β and impact on stroke risk in clinical cohorts
Guangshuai Teng, Minghui Duan, Ke Shang, et al.
Zhonghua Yi Xue Za Zhi
|
June 18, 2015
[Clinical and cytogenetic characteristics of myeloma patients with overall survival less than 24 months]
Junling Zhuang, Wenjiao Tang, Hui Li, et al.
Leukemia Research
|
December 18, 2013
Cytogenetic and clinical risk factors for assessment of ultra high-risk multiple myeloma
Junling Zhuang, Yi Da, Hui Li, et al.
Annals of Hematology
|
January 14, 2017
Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection
Miao Chen, Junling Zhuang, Daobin Zhou, et al.
European Journal of Haematology
|
May 22, 2015
Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia
Miao Chen, Chao Liu, Junling Zhuang, et al.
American Journal of Hematology
|
January 12, 2020
Intravenous methotrexate at a dose of 1 g/m<sup>2</sup> incorporated into RCHOP prevented CNS relapse in high-risk DLBCL patients: A prospective, historic controlled study
Wei Wang, Yan Zhang, Lu Zhang, et al.
Haematologica
|
November 17, 2018
EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis
Alessandro M Vannucchi, Peter A W Te Boekhorst, Claire N Harrison, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
July 3, 2015
[Diagnostic value of three evaluation methods of ¹⁸F-FDG PET/CT in detecting bone marrow infiltration in patients with newly diagnosed diffuse large B-cell lymphoma]
Jiefei Bai, Yingqiang Zhang, Minghui Duan, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
August 13, 2025
Exploring the Molecular Mechanisms and Biological Effects of CELF2 in the Development of Gastric Cancer
Weijian Li, Shengyong Zhai, Xuejian Wang, et al.
Iscience
|
May 1, 2023
Multiomic landscape of immune pathogenesis in Kimura's disease
Xunyao Wu, Anqi Wang, Sumei Zhang, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 12, 2025
TET2 mutations in myeloproliferative neoplasms: potential mediation of atrial fibrillation by interleukin-1β and impact on stroke risk in clinical cohorts
Guangshuai Teng, Minghui Duan, Ke Shang, et al.
Zhonghua Yi Xue Za Zhi
|
June 18, 2015
[Clinical and cytogenetic characteristics of myeloma patients with overall survival less than 24 months]
Junling Zhuang, Wenjiao Tang, Hui Li, et al.
Leukemia Research
|
December 18, 2013
Cytogenetic and clinical risk factors for assessment of ultra high-risk multiple myeloma
Junling Zhuang, Yi Da, Hui Li, et al.
Annals of Hematology
|
January 14, 2017
Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection
Miao Chen, Junling Zhuang, Daobin Zhou, et al.
European Journal of Haematology
|
May 22, 2015
Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia
Miao Chen, Chao Liu, Junling Zhuang, et al.
American Journal of Hematology
|
January 12, 2020
Intravenous methotrexate at a dose of 1 g/m<sup>2</sup> incorporated into RCHOP prevented CNS relapse in high-risk DLBCL patients: A prospective, historic controlled study
Wei Wang, Yan Zhang, Lu Zhang, et al.
Haematologica
|
November 17, 2018
EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis
Alessandro M Vannucchi, Peter A W Te Boekhorst, Claire N Harrison, et al.
Page
of 7